RT Journal Article SR Electronic T1 Bi-allelic variants in CHKA cause a neurodevelopmental disorder with epilepsy and microcephaly JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.10.21.21265050 DO 10.1101/2021.10.21.21265050 A1 Chiara Klöckner A1 J. Pedro Fernandez Murray A1 Mahtab Tavasoli A1 Heinrich Sticht A1 Gisela Stoltenburg-Didinger A1 Leila Motlagh Scholle A1 Somayeh Bakhtiari A1 Michael C. Kruer A1 Hossein Darvish A1 Saghar Ghasemi Firouzabadi A1 Alex Pagnozzi A1 Anju Shukla A1 Katta Mohan Girisha A1 Dhanya Lakshmi Narayanan A1 Parneet Kaur A1 Reza Maroofian A1 Maha S. Zaki A1 Mahmoud M. Noureldeen A1 Andreas Merkenschlager A1 Janina Gburek-Augustat A1 Elisa Cali A1 Selina Banu A1 Kamrun Nahar A1 Stephanie Efthymiou A1 Henry Houlden A1 Rami Abou Jamra A1 Jason Williams A1 Christopher R. McMaster A1 Konrad Platzer YR 2021 UL http://medrxiv.org/content/early/2021/10/31/2021.10.21.21265050.abstract AB The Kennedy pathways catalyze the de novo synthesis of phosphatidylcholine and phosphatidylethanolamine, the most abundant components of eukaryotic cell membranes. In recent years, these pathways have moved into clinical focus since four out of ten genes involved have been associated with a range of autosomal recessive rare diseases such as a neurodevelopmental disorder with muscular dystrophy (CHKB), bone abnormalities and cone-rod dystrophy (PCYT1A), and spastic paraplegia (PCYT2, SELENOI).We identified six individuals from five families with bi-allelic variants in CHKA presenting with severe global developmental delay, epilepsy, movement disorders, and microcephaly. Using structural molecular modeling and functional testing of the variants in a in a cell-based S. cerevisiae model, we determined that these variants reduce the enzymatic activity of CHKA and confer a significant impairment of the first enzymatic step of the Kennedy pathway.In summary, we present CHKA as a novel autosomal recessive gene for a neurodevelopmental disorder with epilepsy and microcephaly.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMT, JPF-M, and CRM were funded by the Canadian Institutes of Health Research. Supported in part by NIH NS106298 to MCK. SE and HH were supported by an MRC strategic award to establish an International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD) MR/S005021/1. Individuals 3 and 5 were collected as part of the SYNaPS Study Group collaboration funded by The Wellcome Trust and strategic award (Synaptopathies) funding (WT093205 MA and WT104033AIA). This research was conducted as part of the Queen Square Genomics group at University College London, supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethics committee of the University of Leipzig, Germany (402/16-ek). All families provided informed consent for clinical testing and publication.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.ACMGAmerican College of Medical GeneticsADPAdenosine diphosphatecMRIcranial MRICOXcytochrome c oxidaseDD/IDdevelopmental delay/intellectual disabilityESexome sequencingH&Ehematoxylin and eosinNMDnonsense-mediated mRNA decayOFCoccipitofrontal circumferenceORFopen reading framePCphosphatidylcholinePEphosphatidylethanolamineRPEretinal pigment epitheliumSDHsuccinate dehydrogenase